✦ LIBER ✦

Sirolimus Does Not Exhibit Nephrotoxicity Compared to Cyclosporine in Renal Transplant Recipients

✍ Scribed by José M. Morales; Lars Wramner; Henri Kreis; Dominique Durand; Josep M. Campistol; Amado Andres; Joaquin Arenas; Eric Nègre; James T. Burke; Carl G. Groth; Sirolimus European Renal Transplant Study Group

Book ID: 114423450
Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 120 KB
Volume: 2
Category: Article
ISSN: 1600-6135
DOI: 10.1034/j.1600-6143.2002.20507.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Atorvastatin does not affect the pharmac

Atorvastatin does not affect the pharmacokinetics of cyclosporine in renal transplant recipients

✍ Monica Hermann; Anders Åsberg; Hege Christensen; Jan Leo Egge Reubsaet; Hallvard 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 202 KB

0339: Does mineralocorticoid receptor an

0339: Does mineralocorticoid receptor antoganism could alleviate cyclosporin-induced nephrotoxicity in renal transplant recipients?

✍ Amador, Cristian; Bertocchio, Jean-Philippe; Hocine, Aldjia; Lancon, Jenny; Mogh 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 47 KB

Trimethoprim–sulphamethoxazole does not

Trimethoprim–sulphamethoxazole does not affect the pharmacokinetics of sirolimus in renal transplant recipients

✍ Ylva Böttiger; Christina Brattström; Lars Bäckman; Kerstin Claesson; James T. Bu 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

Interstitial Fibrosis Quantification in

Interstitial Fibrosis Quantification in Renal Transplant Recipients Randomized to Continue Cyclosporine or Convert to Sirolimus

✍ A. Servais; V. Meas-Yedid; O. Toupance; Y. Lebranchu; A. Thierry; B. Moulin; I. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 400 KB

Late reduction in cyclosporine dosage do

Late reduction in cyclosporine dosage does not improve renal function in pediatric heart transplant recipients

✍ James E Rice; Anne T Shipp; John B Carlin; Suzanna I Vidmar; Robert G Weintraub 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Sirolimus Does Not Absolutely Abolish th

Sirolimus Does Not Absolutely Abolish the Occurrence/Recurrence of Urothelial Carcinoma in Renal Transplant Recipients

✍ S.-M. Wang; H.-C. Tai; S.-C. Chueh; S.-D. Chung; M.-K. Lai 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 54 KB